Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

Also called NCT04850417

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04850417
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT04850417. Randomized; single masking; primary purpose treatment. Start 2021-04-30 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection
Acronym
BA-SCAD
Condition
Spontaneous Coronary Artery Dissection
Intervention (Drug)
Beta blocker, aspirin, clopidogrel
Lead sponsor
Spanish Society of Cardiology (class: other)
Collaborator
Instituto de Investigación Sanitaria Hospital Universitario de la Princesa (class: other)
Collaborator
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa (class: other)

Record details

Record id
cardio:ct-nct04850417
Content hash
800ea911b42da6baefd3443382ce527c826b780def18b99a7e09b1735519d9ab